Pharma Profits
-
The TRIPs waiver and India: A misadventure and a compromise in Geneva by the government
The country has already exported millions of vaccines while more lie unused. Another reason may be that the Centre realised not much would change on the ground.
Yogesh Pai & Prashant Reddy T
-
United States is approving drugs by the dozen. Why is it worrying Indian pharma companies?
Their profits may suffer from increased competition as well as wholesale and retail suppliers teaming up to procure generic medicines.
Sriram Iyer, qz.com
-
India’s oldest drugmaker used some classic management tips to turn profitable after 64 years
Bengal Chemicals & Pharmaceuticals is now eyeing a profit of Rs 20 crore by 2020.
Manu Balachandran, qz.com
Trending
-
‘Be freed from what holds you back’: Poems by Buddhist women from the Murty Classical Library
-
By mixing Carnatic and Hindustani, Mysore’s kings helped create a unique body of music
-
We will leave India if told to break encryption: WhatsApp tells Delhi HC
-
Canada: Amid anti-immigration rhetoric, curbing international students is a knee-jerk reaction
-
Why is BJP wooing Bengali-origin Muslims in Assam?